Related Experiment Video
Updated: Jul 15, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for
Yatrik M Shah1, Keiichirou Morimura, Qian Yang
1National Cancer Institute, Bethesda, MD 20892, USA.
Abstract:
Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) leads to hepatocellular proliferation and liver carcinomas. The early events mediating these effects are unknown. A novel mechanism by which PPARalpha regulates gene expression and hepatocellular proliferation was uncovered. MicroRNA (miRNA) expression profiling demonstrated that activated PPARalpha was a major regulator of hepatic miRNA expression. Of particular interest, let-7C, an miRNA important in cell growth, was inhibited following 4-h treatment and 2-week and 11-month sustained treatment with the potent PPARalpha agonist Wy-14,643 in wild-type mice. let-7C was shown to target c-myc via direct interaction with the 3' untranslated region of c-myc. The PPARalpha-mediated induction of c-myc via let-7C subsequently increased expression of the oncogenic mir-17-92 cluster; these events did not occur in Pparalpha-null mice. Overexpression of let-7C decreased c-myc and mir-17 and suppressed the growth of Hepa-1 cells. Furthermore, using the human PPARalpha-expressing mouse model, which is responsive to Wy-14,643 effects on beta-oxidation and serum triglycerides but resistant to hepatocellular proliferation and tumorigenesis, we demonstrated a critical role for let-7C in liver oncogenesis. Wy-14,643 treatment did not inhibit let-7C or induce c-myc and mir-17 expression. These observations reveal a let-7C signaling cascade critical for PPARalpha agonist-induced liver proliferation and tumorigenesis.
Insights
Peroxisome proliferator-activated receptor alpha (PPARalpha) activation drives liver cancer by inhibiting let-7C microRNA, which normally suppresses cell growth. This pathway is crucial for PPARalpha agonist-induced liver proliferation and tumorigenesis.
Area of Science:
- Hepatology
- Molecular Biology
- Oncology
Background:
- Peroxisome proliferator-activated receptor alpha (PPARalpha) activation is linked to liver cancer development.
- The precise early molecular events driving PPARalpha-mediated hepatocellular proliferation remain largely unknown.
Purpose of the Study:
- To elucidate a novel mechanism by which PPARalpha regulates gene expression and hepatocellular proliferation.
- To investigate the role of microRNAs (miRNAs) in PPARalpha-mediated liver oncogenesis.
Main Methods:
- MicroRNA (miRNA) expression profiling in wild-type and Pparalpha-null mice treated with PPARalpha agonist Wy-14,643.
- Analysis of let-7C targeting of c-myc and its downstream effects on the mir-17-92 cluster.
- Validation in a human PPARalpha-expressing mouse model resistant to hepatocellular proliferation.
Main Results:
- PPARalpha activation significantly altered hepatic miRNA expression, notably inhibiting let-7C.
- let-7C directly targets c-myc, and its inhibition by PPARalpha leads to c-myc and mir-17-92 cluster upregulation.
- In a humanized mouse model resistant to proliferation, Wy-14,643 did not inhibit let-7C or induce c-myc/mir-17, confirming let-7C's critical role.
Conclusions:
- A let-7C signaling cascade is essential for PPARalpha agonist-induced liver proliferation and tumorigenesis.
- PPARalpha agonists inhibit let-7C, leading to c-myc induction and subsequent oncogenic events.
- Targeting the let-7C pathway may offer therapeutic strategies for PPARalpha-related liver diseases.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
MAPK Signaling Cascades
Peroxisomes
Peroxisomes
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
